Keryx Biopharmaceuticals (KERX) Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco, Inc. and Torii Pharmaceutical Co.
4/23/2012 10:40:56 AM
More...
|
Merck & Co., Inc. (MRK) Ditches Bone Drug Deal with Japan Tobacco, Inc.
10/17/2011 8:36:16 AM
More...
|
Keryx Biopharmaceuticals (KERX) Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex(TM)) in Japan by Partner, Japan Tobacco, Inc. and Torii Pharmaceutical Co.
4/18/2011 7:00:20 AM
More...
|
Japan Tobacco's Novel Osteoporosis Drug Promising in Early Study
9/17/2009 11:17:03 AM
More...
|
Orphagen Pharmaceuticals Announces Collaboration And License Agreement With Japan Tobacco
1/7/2009 11:13:09 AM
More...
|
Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal
9/25/2008 6:42:47 AM
More...
|
Keryx Biopharmaceuticals (KERX) Licenses Rights to Japan Tobacco; Torii Pharmaceutical Co. to Pay up to $100 Million
9/26/2007 6:38:51 AM
More...
|
Arcadia Biosciences, Inc. Licenses Corn And Rice Transformation Technology From Japan Tobacco
10/4/2006 11:44:53 AM
More...
|
Japan Tobacco And GlaxoSmithKline (GSK) Conclude Licensing Agreement For New Drug Candidate
4/20/2006 11:04:07 AM
More...
|
Two New Anti-HIV Drugs Launched By Japan Tobacco And Torii Pharmaceutical Co.
10/19/2005 5:13:14 PM
More...
|
|